SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001596783-24-000082
Filing Date
2024-08-29
Accepted
2024-08-29 07:47:27
Documents
15
Period of Report
2024-08-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctlt-20240829.htm   iXBRL 8-K 29107
2 EX-99.1 earningsreleaseex991-fy24x.htm EX-99.1 549159
6 image1a.jpg GRAPHIC 45267
  Complete submission text file 0001596783-24-000082.txt   799811

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctlt-20240829.xsd EX-101.SCH 2209
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctlt-20240829_lab.xml EX-101.LAB 22392
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctlt-20240829_pre.xml EX-101.PRE 13095
17 EXTRACTED XBRL INSTANCE DOCUMENT ctlt-20240829_htm.xml XML 2707
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 241258721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)